Former FAER Grantee to Help Lead Ambitious Global Study of Chloroquine

Former Foundation for Anesthesia Education and Research (FAER) grantee Michael S. Avidan, B.Ch., M.B., FRCA, will lead a new trial testing the anti-malaria drug chloroquine to determine whether it can prevent COVID-19 or decrease its severity. With $9 million in philanthropic support, the COVID-19 Research Outcomes Worldwide Network (CROWN) Collaborative will test an estimated 30,000 health workers worldwide. The trial will be coordinated from Washington University School of Medicine in St. Louis. Read more from the Washington University School of Medicine.